For more than a quarter century, genomics has made transformative progress toward solutions to global challenges. Advances in lab automation, sequencing, artificial intelligence, bioinformatics and analysis have expanded capabilities and… Read More
Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global… Read More
VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is… Read More
MISSISSAUGA, ON – Hoffmann-La Roche Limited (Roche Canada) announced that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for TECENTRIQ SC (atezolizumab) on November 19, 2024. The pCPA… Read More
Targeted radioligand therapy closer to public reimbursement for eligible Canadian patients with PSMA-positive metastatic castration-resistant prostate cancer MONTREAL, QC – Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the successful… Read More
